Ecofibre Limited (EOFBF)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Ecofibre Limited (EOFBF) with AI Score 40/100 (Weak). Ecofibre Limited cultivates, manufactures, and sells hemp-based products across health, food, and textile sectors in the United States and Australia. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 18, 2026Ecofibre Limited (EOFBF) Healthcare & Pipeline Overview
Ecofibre Limited operates in the hemp industry, focusing on CBD products, hemp-based foods, and textiles across the US and Australia. With a negative profit margin and a high beta, the company navigates a complex regulatory environment while competing with established players in the specialty drug and consumer goods markets.
Investment Thesis
Investing in Ecofibre Limited presents a high-risk, high-reward scenario. The company's negative profit margin of -158.5% indicates significant challenges in achieving profitability. Growth catalysts include expansion of product lines within the Ananda Health segment and increased market penetration in the US and Australian markets. The company's high beta of 2.28 suggests significant volatility relative to the broader market. Successful navigation of regulatory hurdles and achieving economies of scale in production and distribution are critical for long-term value creation. Investors should closely monitor the company's progress in improving its financial performance and establishing a sustainable competitive advantage.
Based on FMP financials and quantitative analysis
Key Highlights
- Market capitalization of $0.00B indicates the company's small size and potential for growth, but also higher risk.
- Negative P/E ratio of -0.16 reflects the company's current lack of profitability.
- Profit margin of -158.5% highlights significant challenges in achieving sustainable profitability.
- Gross margin of -3.9% indicates that the cost of goods sold exceeds revenue, requiring substantial improvements in operational efficiency.
- Beta of 2.28 suggests high volatility compared to the overall market, potentially offering higher returns but also greater risk.
Competitors & Peers
Strengths
- Vertically integrated operations.
- Proprietary genetics in hemp breeding.
- Established brands in the CBD and hemp food markets.
- Operations in both the United States and Australia.
Weaknesses
- Negative profit margin.
- High beta indicating significant volatility.
- Limited brand recognition compared to larger competitors.
- Reliance on evolving regulations.
Catalysts
- Upcoming: Potential regulatory changes in the US and Australia regarding hemp-derived products could create new market opportunities.
- Ongoing: Expansion of distribution channels and retail partnerships to increase product availability.
- Ongoing: Development and launch of new CBD products targeting specific health conditions.
Risks
- Potential: Negative profit margin and challenges in achieving profitability.
- Potential: High beta indicating significant volatility.
- Ongoing: Intense competition from other hemp companies.
- Ongoing: Evolving and uncertain regulatory environment.
- Potential: Fluctuations in commodity prices for hemp.
Growth Opportunities
- Expansion of Ananda Health Product Line: The market for CBD products is projected to reach $16 billion by 2026. Ecofibre can capitalize on this growth by expanding its Ananda Health product line to include new formulations, delivery methods, and targeted health solutions. This includes developing products for specific conditions such as anxiety, sleep disorders, and pain management. Success hinges on effective marketing, product innovation, and compliance with evolving regulations.
- Increased Market Penetration in the United States: The US market represents a significant opportunity for Ecofibre. By strengthening its distribution network, enhancing its marketing efforts, and building brand awareness, the company can increase its market share in key states. This includes targeting specific demographic groups and leveraging e-commerce platforms to reach a wider audience. Success depends on effective execution of its sales and marketing strategies.
- Development of Hemp-Based Textile Products: The market for sustainable textiles is growing rapidly, driven by increasing consumer awareness of environmental issues. Ecofibre can leverage its Hemp Black segment to develop innovative hemp-based textile products for various applications, including apparel, home furnishings, and industrial materials. This includes partnering with fashion brands and manufacturers to promote the use of hemp fabrics. The timeline for significant revenue generation is estimated at 2-3 years.
- Strategic Partnerships and Acquisitions: Ecofibre can accelerate its growth by forming strategic partnerships with other companies in the hemp industry or acquiring complementary businesses. This includes partnering with retailers, distributors, and technology providers to expand its reach and enhance its capabilities. Potential acquisition targets include companies with established brands, proprietary technologies, or strong distribution networks. The timeline for realizing the benefits of such partnerships or acquisitions is estimated at 1-2 years.
- Expansion into International Markets: While Ecofibre currently operates in the United States and Australia, there are opportunities to expand into other international markets with favorable regulatory environments for hemp-derived products. This includes countries in Europe, Asia, and Latin America. Market entry strategies may include establishing local partnerships, setting up distribution networks, or acquiring existing businesses. The timeline for successful international expansion is estimated at 2-3 years.
Opportunities
- Expansion of product lines within the Ananda Health segment.
- Increased market penetration in the United States.
- Development of hemp-based textile products.
- Strategic partnerships and acquisitions.
Threats
- Intense competition from other hemp companies.
- Evolving and uncertain regulatory environment.
- Fluctuations in commodity prices for hemp.
- Potential changes in consumer preferences.
Competitive Advantages
- Vertically integrated operations provide control over quality and costs.
- Proprietary genetics in hemp breeding.
- Established brands in the CBD and hemp food markets.
About EOFBF
Ecofibre Limited, established in 2009 and based in Sydney, Australia, is a vertically integrated company focused on the hemp industry. The company breeds, grows, manufactures, markets, and sells a range of hemp-derived products across its three primary segments: Ananda Health, Ananda Food, and Hemp Black. Ananda Health focuses on CBD products for human and pet consumption, including oils, capsules, and topical creams, targeting the growing market for natural health and wellness solutions. Ananda Food develops and markets hemp-related food products, such as hemp seeds, protein powders, and snacks, catering to health-conscious consumers seeking plant-based alternatives. Hemp Black is dedicated to the development and commercialization of textile and hemp-based products, including sustainable fabrics and industrial materials. Ecofibre's operations span the United States and Australia, reflecting its strategy to capitalize on the evolving regulatory landscape and growing consumer demand for hemp-derived products. The company faces challenges related to profitability, competition, and regulatory uncertainty in the rapidly evolving hemp industry.
What They Do
- Breeds and cultivates hemp plants.
- Manufactures CBD products for human and pet consumption.
- Develops and markets hemp-related food products.
- Creates textile and hemp-based products.
- Markets and sells its products in the United States and Australia.
- Operates through Ananda Health, Ananda Food, and Hemp Black segments.
Business Model
- Vertical integration: Controls the entire value chain from breeding to sales.
- Direct-to-consumer sales: Utilizes online channels to reach customers directly.
- Wholesale distribution: Partners with retailers to distribute products through physical stores.
Industry Context
Ecofibre Limited operates within the rapidly evolving hemp industry, which is experiencing significant growth due to increasing legalization and consumer acceptance of hemp-derived products. The market is highly competitive, with numerous players offering similar products. Key trends include the increasing demand for CBD products for health and wellness, the growing popularity of plant-based foods, and the rising interest in sustainable textiles. Ecofibre competes with companies like AHFGIF, CNTMF, CWBHF, ELXMF, and EVRRF, which are also focused on various segments of the hemp market. The industry is subject to evolving regulations, which can significantly impact the company's operations and growth prospects.
Key Customers
- Health-conscious consumers seeking natural health and wellness solutions.
- Pet owners looking for CBD products for their pets.
- Consumers interested in plant-based food alternatives.
- Manufacturers and brands seeking sustainable textile materials.
Financials
Chart & Info
Ecofibre Limited (EOFBF) stock price: Price data unavailable
Latest News
No recent news available for EOFBF.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for EOFBF.
Price Targets
Wall Street price target analysis for EOFBF.
MoonshotScore
What does this score mean?
The MoonshotScore rates EOFBF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Ulrich Tombuelt
CEO
Ulrich Tombuelt's background is not fully detailed in the provided data. However, as CEO, he is responsible for the overall strategic direction and operational performance of Ecofibre Limited. His role involves overseeing the company's various segments, including Ananda Health, Ananda Food, and Hemp Black, and ensuring the effective execution of its growth strategies. He likely has experience in the healthcare or consumer goods industries, with a focus on marketing, sales, and product development.
Track Record: Due to the limited information available, Ulrich Tombuelt's specific achievements and strategic decisions at Ecofibre Limited cannot be detailed. However, as CEO, he is likely responsible for guiding the company through the evolving regulatory landscape and driving its efforts to achieve profitability and sustainable growth. His performance is likely evaluated based on the company's financial results, market share, and product innovation.
EOFBF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Ecofibre Limited may not meet the minimum financial or regulatory requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, be undergoing restructuring, or have other factors that prevent them from listing on a higher tier. Investing in companies on the OTC Other tier carries significant risks due to the lack of transparency and regulatory oversight compared to exchanges like the NYSE or NASDAQ. This tier is generally associated with higher volatility and lower liquidity.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases the risk of investing in EOFBF.
- Low trading volume can lead to price volatility.
- Wider bid-ask spreads can increase transaction costs.
- OTC Other tier indicates a higher level of risk compared to listed exchanges.
- Potential for fraud or manipulation is higher on the OTC market.
- Verify the company's financial statements and disclosures.
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Understand the regulatory environment for the company's products.
- Evaluate the company's liquidity and trading volume.
- Consult with a financial advisor before investing.
- Confirm the legitimacy of the company's operations and assets.
- The company has been in operation since 2009.
- Ecofibre has operations in both the United States and Australia.
- The company has a diversified product portfolio across health, food, and textile segments.
EOFBF Healthcare Stock FAQ
What does Ecofibre Limited do?
Ecofibre Limited is a vertically integrated company that cultivates, manufactures, and sells hemp-derived products across three segments: Ananda Health, Ananda Food, and Hemp Black. Ananda Health focuses on CBD products for human and pet consumption, including oils, capsules, and topical creams. Ananda Food develops and markets hemp-related food products, such as hemp seeds and protein powders. Hemp Black is dedicated to the development and commercialization of textile and hemp-based products. The company operates in the United States and Australia, targeting health-conscious consumers and businesses seeking sustainable materials.
What do analysts say about EOFBF stock?
Given the lack of analyst coverage data, a comprehensive analysis of analyst opinions on EOFBF stock is unavailable. However, key valuation metrics such as the negative P/E ratio and profit margin suggest that the company faces significant challenges in achieving profitability. Growth considerations include the potential for expansion in the CBD market and the development of sustainable textile products. Investors should conduct their own due diligence and consider the risks associated with investing in a small-cap company operating in a rapidly evolving industry.
What are the main risks for EOFBF?
The main risks for Ecofibre Limited include its negative profit margin and challenges in achieving profitability, as evidenced by its -158.5% profit margin. The company also faces intense competition from other hemp companies and an evolving regulatory environment that could impact its operations and growth prospects. Fluctuations in commodity prices for hemp and potential changes in consumer preferences also pose risks. Additionally, the company's high beta of 2.28 indicates significant volatility compared to the overall market.
How does Ecofibre Limited navigate regulatory approval processes?
Identify Ecofibre Limited's expansion into new therapeutic areas, geographic markets, or healthcare segments.
What are the key growth opportunities for EOFBF in healthcare?
Ecofibre Limited has several key growth opportunities within the healthcare sector, primarily through its Ananda Health segment. These opportunities include expanding its product line to target specific health conditions such as anxiety, sleep disorders, and pain management. The company can also explore new delivery methods for its CBD products, such as transdermal patches or inhalers. Furthermore, Ecofibre can expand its geographic reach within the United States and Australia, targeting new markets and demographic groups. Strategic partnerships with healthcare providers and retailers can also drive growth. Success depends on product innovation, effective marketing, and compliance with evolving regulations.
What are the key factors to evaluate for EOFBF?
Ecofibre Limited (EOFBF) currently holds an AI score of 40/100, indicating low score. Key strength: Vertically integrated operations.. Primary risk to monitor: Potential: Negative profit margin and challenges in achieving profitability.. This is not financial advice.
How frequently does EOFBF data refresh on this page?
EOFBF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven EOFBF's recent stock price performance?
Recent price movement in Ecofibre Limited (EOFBF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Vertically integrated operations.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited financial data available for in-depth analysis.
- OTC market investments carry higher risks.
- AI analysis pending for further insights.